Hongsheng Dai | Pharmacogneomics and Personalized medicine | Best Researcher Award 

Prof Hongsheng Dai | Pharmacogneomics and personalized medicine | Best Researcher Award 

Newcastle University | United Kingdom

Author Profile

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Hongsheng Dai pursued his academic journey with a B.Sc. in Applied Mathematics from Tianjin University, followed by an M.Sc. in Statistics from Beijing University, where he focused on survival analysis. He furthered his studies with a D.Phil. in Statistics from the University of Oxford, specializing in perfect Monte Carlo simulation techniques.

Professional Endeavors

Dai's professional journey showcases a progression from lecturer roles to professorships, demonstrating his dedication and expertise in the field of statistics. He held positions at various prestigious institutions, including Lancaster University, Brighton University, and the University of Essex, before assuming his current role as a Professor in Statistics at Newcastle University.

Contributions and Research Focus on Pharmacogenomics and personalized medicine

Dai's research interests encompass a broad spectrum of statistical methodologies, including exact Monte Carlo simulations, Bayesian computational methods, graphical models, mixture models, and survival analysis. His notable contributions include advancements in coupling from the past, path-space rejection sampling, Bayesian fusion, and nonparametric survival analysis for both censored and truncated bivariate data.

Impact and Influence

Dai's research has garnered significant recognition, as evidenced by the grants he has secured, such as the ERC Synergy Grant and EPSRC funding. His work on responsible AI for gender and ethnic labor market equality reflects his commitment to addressing societal challenges through statistical methodologies.

Academic Citations

Dai's work has likely garnered citations in various academic publications, particularly in the fields of statistics, computational methods, and applied mathematics, given the breadth and depth of his research contributions.

Legacy and Future Contributions

Dai's legacy lies in his substantial contributions to statistical methodologies, particularly in exact Monte Carlo simulations and survival analysis. His interdisciplinary collaborations and innovative approaches have positioned him as a leader in the field. Looking forward, Dai is poised to continue making significant contributions to statistical research, with potential applications in diverse domains.

Notable Publications

Balancing Gender Bias in Job Advertisements With Text-Level Bias Mitigation 2022(7)

The role of insulators and transcription in 3D chromatin organization of flies 2022(18)

Xukun Deng | Pharmacogenomics and Personalized Medicine | Excellence Award

Prof. Xukun Deng | Pharmacogenomics and Personalized Medicine | Excellence Award

South-Central Minzu University | China

Author Profile 

Scopus

EARLY ACADEMIC PURSUITS:

Dr. XU-KUN DENG commenced his academic journey by obtaining a Bachelor of Science degree in PHARMACY from the Department of Pharmacy at ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE between 1990 and 1994.

PROFESSIONAL ENDEAVORS:

In his pursuit of academic excellence, Dr. DENG furthered his studies at the School of Pharmacy, NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, from 2000 to 2006. During this period, he demonstrated exceptional dedication and prowess, earning a Ph.D. degree in TRADITIONAL CHINESE MEDICINE. His academic achievements were recognized with the prestigious QIUSHI SCHOLARSHIP in HONG KONG in 2006.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENOMICS AND PERSONALIZED MEDICINE:

Since 2007, Dr. DENG has held the position of a PROFESSOR and POSTGRADUATE TUTOR at the School of Pharmacy, SOUTH-CENTRAL MINZU UNIVERSITY. His extensive contributions to the field encompass a broad spectrum, including PHARMACOLOGY, NATURAL MEDICINE CHEMISTRY, and CHINESE MEDICINE PROCESSING.

IMPACT AND INFLUENCE:

Dr. DENG's work holds significant impact, particularly in the realms of GASTROINTESTINAL PHARMACOLOGY and TUMOR PHARMACOLOGY. His dedication to uncovering NEW ACTIVE CONSTITUENTS of TRADITIONAL CHINESE MEDICINE underscores his commitment to advancing scientific knowledge and medical practices.

ACADEMIC CITATIONS:

His research contributions have garnered recognition, evident in the academic world through numerous citations and acknowledgments. Dr. DENG's work has left a lasting imprint on the academic landscape, influencing fellow researchers and contributing to the collective knowledge in his areas of expertise.

LEGACY AND FUTURE CONTRIBUTIONS:

As a respected figure in his field, Dr. XU-KUN DENG's legacy is marked by a commitment to excellence and a profound impact on the understanding of Traditional Chinese Medicine. His continued dedication to research and education positions him as a beacon for future scholars and practitioners in the field. The legacy he is building promises to shape the trajectory of research in pharmacology, natural medicine chemistry, and Chinese medicine processing for years to come.

Notable Publications

Theaflavine inhibits hepatic stellate cell activation by modulating the PKA/LKB1/AMPK/GSK3β cascade and subsequently enhancing Nrf2 signaling 2023(4)

Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl4-induced liver fibrosis in mice via upregulating Smad7 and subsequent suppression of TGF-β/Smad cascade 2022 (15)

A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl4-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade 2021(8)